About Pricing FAQs Blog

Loading clinical trials...

Your health journey, clearly organized.

Find Clinical Trials →

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

International BPA Registry | Clinical Trials | Clareo Health

Back to clinical trial search

COMPLETEDNCT03245268

International BPA Registry

The International Balloon Pulmonary Angioplasty (BPA) Registry is a prospective, multi-center, long-term observational project. Scheduled to start data collection in Q4 2017, the registry will run for...

Lead sponsor: International CTEPH Association•5 U.S. locations•View source on ClinicalTrials.gov

Clareo plain-language summary

What this study is about

Generating AI summary...

Save this trial guide to your notes

Keep your clinical trial research organized — questions to ask, what to expect, and key details.

Sponsors

Lead Sponsor

International CTEPH Association

Age

All ages

Sex

ALL

Healthy Volunteers

No

Inclusion Criteria

•Diagnosis with CTEPH according to the following criteria:
•* Mean PAP ≥ 25mmHg at rest; or if mean PAP \< 25mmHg at rest, have exercise limitations from chronic thromboembolic disease
•* Abnormal ventilation perfusion lung scanning (VQ) scan, pulmonary angiogram, computer tomographic pulmonary angiogram, or magnetic resonance pulmonary angiogram confirming chronic thromboembolic disease as recommended by standard guidelines
•Treatment with anticoagulation for ≥ 3 months before diagnosis of CTEPH
•Naïve to BPA treatment
•Scheduled to undergo their first BPA session ≥ 1 day after enrollment. Enrollment is defined as date the consent is signed by the patient. Enrollment must occur before any BPA session
•Willing to provide informed consent

Exclusion Criteria

•BPA treatment prior to enrollment
•Pulmonary hypertension cause other than World Health Organization (WHO) group IV (CTEPH)
•Targeted BPA treatment lesion other than from WHO group IV (CTEPH)

Related studies

RECRUITINGPhase 2

129Xe MRI Cardiopulmonary

NCT06038630 · Interstitial Lung Disease, Chronic Thromboembolic Pulmonary Hypertension, and more

Chinese PE Multimodality Imaging Artificial Intelligence Study

NCT06526468 · Pulmonary Embolism, Chronic Thromboembolic Pulmonary Hypertension, and more

Safety and Efficacy of Balloon Pulmonary Angioplasty in China

NCT04206852 · Chronic Thromboembolic Pulmonary Hypertension

Enrolling By Invitation

Endtidal Carbon Dioxide for Earlier Detection of Pulmonary Hypertension

NCT03388476 · Hypertension, Pulmonary, Hypertension;Pulmonary;Primary, and more

Not Yet Recruiting

What is the Role of the Exposome in Pulmonary Hypertension

NCT07172334 · Pulmonary Arterial Hypertension (PAH), Chronic Thromboembolic Pulmonary Hypertension (CTEPH)

View all related studies →

Data from ClinicalTrials.govLast updated on ClinicalTrials.gov: June 10, 2022Terms

Trial snapshot

StatusCOMPLETED

Phase—

Enrollment500

Start dateMar 2018

Last updatedJun 10, 2022

Condition

Chronic Thromboembolic Pulmonary Hypertension CTEPH

Locations shown

University of California San Diego

La Jolla, California

Massachusetts General Hospital

Boston, Massachusetts

Mayo Clinic

Rochester, Minnesota

For caregivers

Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.

Start free trial →

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: June 10, 2022Data synced to Clareo: May 25, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions